China Advisory Services

Navigating China's dynamic development and commercial environment.

 

Whether you are exploring the idea of doing business in China, or you’re already there, our new China Advisory Service team can carefully guide you through the intricate and changing regulatory and market access landscape.

Our people take the time to deeply understand your details to give you the best regulatory, developmental, and commercial advice. And because we understand the specifics of the region, we can help guide you to becoming a Market Authorization Holder in China and keep everything NMPA-compliant along the way.

Parexel has a deep bench of former CFDA/NMPA Regulators on statff who shaped and implemented regulations in China. And now - their expertise is available to you. 

 

Our China Advisory Services include:

  • Regulatory strategy and planning
  • Regulatory submissions and translated eCTD
  • Strategic risk and compliance management
  • Clinical development planning and execution
  • Market Access Support
  • Commercialization strategy

 

Our China Advisory Team Includes: 

4 Ex-FDA

3 Ex-NMPA/CFDA Regulators

8 Dedicated China Regulatory Consultants, Clinical Development, Market Access and Commercial Experts

 

We are always available for a conversation.

*